Akin Gump and Baker Botts, meanwhile, would both seamlessly slot into Norton Rose’s growing energy and natural resources practice, while the new life sciences headlight could bring some West Coast firms into play. Here, Morrison & Foerster would be a strong contender, although MoFo’s Asian offices might overlap too much with Norton Rose’s. And Orrick, Herrington & Sutcliffe’s repeated desire to merge with a U.K. firm—it recently held talks with SJ Berwin—means that it shouldn’t be ruled out.
However, the smart money, according to several partners at Norton Rose, is Fulbright & Jaworski. Four London-based equity partners say that the two firms held tentative merger discussions in 2008. Martyr denies this, but admits that he is close to Fulbright chairman Steven Pfeiffer, who used to regularly refer him litigation work when Pfeiffer worked in the firm’s London office in the early 1980s. (Fulbright did not respond to a request for comment.)
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
